申请人:Kymera Therapeutics, Inc.
                            
                            
                                公开号:US20210002296A1
                            
                            
                                公开(公告)日:2021-01-07
                            
                            The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders.